Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours.
10 auth. J.J.E.M. Kitzen, Maja J.A. de Jonge, C. Lamers, F. Eskens, D. Biessen, L. Doorn, ... J. T. Steeg, M. Brandely, C. Puozzo, Jaap Verweij